Ellevest Inc’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Ellevest Inc’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5	Closed	–	–	1778
2022 Q1	$0	Buy	+5	New	+$79	﹤0.01%	1689

Other funds holding ICVX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ellevest Inc's ICVX Position: Q2 2022 in Review

Ellevest Inc sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2022, closing a stake of 5 shares.

Ellevest Inc first reported a position in ICVX in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 57 funds tracked by Wall St. Rank hold ICVX as of Q2 2022.

Ellevest Inc reported no remaining Icosavax, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ellevest Inc sold 5 Icosavax, Inc. Common Stock shares in Q2 2022.
Ellevest Inc first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
Ellevest Inc's Icosavax, Inc. Common Stock position peaked at $0 in Q1 2022.
57 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2022.

Based on Ellevest Inc's 13F filing for Q2 2022, filed 18 Jul 2022.